(S)-2-(1-(9H-purin-6-yl)pyrrolidin-2-yl)-3-cyclobutyl-5-fluoroquinazolin-4(3H)-one

ID: ALA4526482

PubChem CID: 155544223

Max Phase: Preclinical

Molecular Formula: C21H20FN7O

Molecular Weight: 405.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1C1CCC1

Standard InChI:  InChI=1S/C21H20FN7O/c22-13-6-2-7-14-16(13)21(30)29(12-4-1-5-12)19(27-14)15-8-3-9-28(15)20-17-18(24-10-23-17)25-11-26-20/h2,6-7,10-12,15H,1,3-5,8-9H2,(H,23,24,25,26)/t15-/m0/s1

Standard InChI Key:  ISLWSZCNCHXUKN-HNNXBMFYSA-N

Molfile:  

 
     RDKit          2D

 30 35  0  0  0  0  0  0  0  0999 V2000
   19.4283   -7.9193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2038   -8.1932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7045   -7.5400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2338   -6.8618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4487   -7.0994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8925   -5.8689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8914   -6.6925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6036   -7.1015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6018   -5.4559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3145   -5.8653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3134   -6.6901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0237   -7.0991    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7397   -6.6921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7409   -5.8673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0260   -5.4496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0260   -4.6282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7170   -8.3246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0102   -7.9021    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2952   -8.3068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2866   -9.1284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7109   -9.1409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1687  -10.3403    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9782  -10.4283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3106   -9.6854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9947   -9.5339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5993   -4.6346    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.4488   -5.4585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2418   -5.6719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4593   -4.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6664   -4.6655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  6  7  2  0
  7  8  1  0
  8 11  2  0
 10  9  2  0
  9  6  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
  5 13  1  6
  1 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 21 17  1  0
 21 25  2  0
 25 22  1  0
 22 23  1  0
 23 24  2  0
 24 21  1  0
 20 25  1  0
  9 26  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 27  1  0
 14 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4526482

    ---

Associated Targets(Human)

SU-DHL-6 (338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CD Tclin PI3-kinase p110-delta subunit (6699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.44Molecular Weight (Monoisotopic): 405.1713AlogP: 3.27#Rotatable Bonds: 3
Polar Surface Area: 92.59Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.83CX Basic pKa: 3.94CX LogP: 2.77CX LogD: 2.77
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -0.98

References

1. Ma X, Fang F, Tao Q, Shen L, Zhong G, Qiao T, Lv X, Li J..  (2019)  Conformationally restricted quinazolone derivatives as PI3Kδ-selective inhibitors: the design, synthesis and biological evaluation.,  10  (3): [PMID:30996859] [10.1039/C8MD00556G]

Source